# Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer

> **NCT01206218** · PHASE2,PHASE3 · UNKNOWN · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 96 (estimated)

## Conditions studied

- Advanced Gastric Cancer

## Interventions

- **DRUG:** FLOT Regimen
- **DRUG:** FLO Regimen or FLOT Regimen

## Key facts

- **NCT ID:** NCT01206218
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2012-10
- **Final completion:** —
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2010-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01206218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01206218, "Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT01206218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*